Like other GLP-1-related medications, Mounjaro affects appetite, blood sugar regulation, insulin response, and gastric emptying, which may help some patients lose weight
The Nutrient Gap Nobody Budgets For GLP-1 drugs work by dramatically reducing appetite which is the point, but it comes with a side effect rarely discussed: eating far less food means eating far fewer micronutrients too, on top of whatever gut absorption changes are already happening
This content cannot be viewed by non-subscribers/non-members.
*Disclaimer: Major Players sorted in no particular order Recent Industry Developments March 2023: Novo Nordisk announced headline results from the PIONEER PLUS trial, a phase 3b, 68-week efficacy and safety trial with once-daily oral semaglutide 25 mg and 50 mg versus 14 mg as an add-on to a stable dose of 1-3 oral antidiabetic medicines in people with type 2 diabetes in need of treatment intensification
This program utilizes the power of GLP-1 (glucagon-like peptide-1) medication to shed unwanted pounds
(2017) the researchers observed mitochondrial fragmentation and ultrastructural damage in the brains of APP transgenic mice using confocal microscopy and electron microscopy
